Glaukos Corp (GKOS): Shareholders' Equity
$656.15M
As of 2025-12-31
$682.49M
As of 2026-06-30
+7.4%
3-year compound annual growth
-0.3%
5-year compound annual growth
+21.3%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $656.15M | -14.4% | 2026-02-23, Balance as of period end |
| 2024-12-31 | $766.93M | +66.1% | 2026-02-23, Balance as of period end |
| 2023-12-31 | $461.77M | -12.9% | 2026-02-23, Balance as of period end |
| 2022-12-31 | $530.00M | -9.7% | 2025-02-25, Balance as of period end |
| 2021-12-31 | $587.15M | -12.0% | 2024-02-23, Balance as of period end |
| 2020-12-31 | $667.45M | -0.9% | 2023-02-24, Balance as of period end |
| 2019-12-31 | $673.27M | +287.2% | 2022-02-28, Balance as of period end |
| 2018-12-31 | $173.86M | +25.8% | 2021-03-01, Balance as of period end |
| 2017-12-31 | $138.20M | +17.8% | 2020-03-02, Balance as of period end |
| 2016-12-31 | $117.27M | +23.2% | 2019-02-28, Balance as of period end |
| 2015-12-31 | $95.19M | n/m | 2018-02-28, Balance as of period end |
| 2014-12-31 | -$160.90M | n/m | 2017-03-15, Balance as of period end |
| 2013-12-31 | -$149.04M | n/a | 2016-03-15, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Glaukos Corp (GKOS) | 2025-12-31 | $656.15M | -14.4% |
| AtriCure, Inc. (ATRC) | 2025-12-31 | $491.94M | +6.7% |
| Bioventus Inc. (BVS) | 2025-12-31 | $184.10M | +24.4% |
| Artivion, Inc. (AORT) | 2025-12-31 | $448.23M | +62.3% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $423.88M | +23.7% |
| Mimedx Group, Inc. (MDXG) | 2025-12-31 | $256.55M | +32.9% |
| Accuray Inc (ARAY) | 2026-06-30 | $41.70M | -48.6% |
| NovoCure Ltd (NVCR) | 2025-12-31 | $340.47M | -5.5% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $152.75M | +68.0% |
Compare GKOS, ATRC, BVS, AORT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗